Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Hsia K et al. Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitro. 2017 Acta Biomater pmid:28110073
Maiti A et al. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival. 2017 Cell. Signal. pmid:28108260
Meissner A et al. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension. 2017 Cardiovasc. Res. pmid:28082452
Atkinson D et al. Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy. 2017 Neurology pmid:28077491
Ng ML et al. The role of sphingolipid signalling in diabetes‑associated pathologies (Review). 2017 Int. J. Mol. Med. pmid:28075451
Barnawi J et al. Reduced DNA methylation of sphingosine-1 phosphate receptor 5 in alveolar macrophages in COPD: A potential link to failed efferocytosis. 2017 Respirology pmid:27868302
Frias MA et al. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia. 2017 Eur. J. Clin. Invest. pmid:27861771
Fang V et al. Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response. 2017 Nat. Immunol. pmid:27841869
Wang R et al. Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. 2017 Am. J. Pathol. pmid:27840081
O'Sullivan S and Dev KK Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases. 2017 Neuropharmacology pmid:27825807
Engel N et al. Synergistic Action of Genistein and Calcitriol in Immature Osteosarcoma MG-63 Cells by SGPL1 Up-Regulation. 2017 PLoS ONE pmid:28125641
Yanagida K and Hla T Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient. 2017 Annu. Rev. Physiol. pmid:27813829
Sánchez DI et al. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma. 2017 J. Pineal Res. pmid:27696512
Smith P et al. Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic Hematopoietic Stem Cell Transplantation. 2017 Int J Mol Sci pmid:28934113
Anjum I et al. Enhancement of S1P-induced contractile response in detrusor smooth muscle of rats having cystitis. 2017 Eur. J. Pharmacol. pmid:28882559
Pierucci F et al. Non-dioxin-like organic toxicant PCB153 modulates sphingolipid metabolism in liver progenitor cells: its role in Cx43-formed gap junction impairment. 2017 Arch. Toxicol. pmid:27318803
Haddadi N et al. "Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer. 2017 Int J Mol Sci pmid:28869494
Bosteen MH et al. Effects of apolipoprotein M in uremic atherosclerosis. 2017 Atherosclerosis pmid:28866363
Olesch C et al. Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation. 2017 Mediators Inflamm. pmid:28848247
Mitroi DN et al. SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production. 2017 Autophagy pmid:28521611
Egom EE et al. Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry. 2017 Int J Mol Sci pmid:28820460
Kurano M et al. Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes. 2017 PLoS ONE pmid:28494002
Azimzadeh K et al. Evaluation of plasma sphingosine 1-phosphate, hepcidin and cardiovascular damage biomarkers (cardiac troponin I and homocysteine) in rats infected with brucellosis and vaccinated (Rev-1, RB-51). 2017 Microb. Pathog. pmid:28533142
Oh YT et al. DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion. 2017 Cell Commun. Signal pmid:28482915
Fan Q et al. Sphingosine-1-phosphate promotes ovarian cancer cell proliferation by disrupting Hippo signaling. 2017 Oncotarget pmid:28460443
Lafargue A et al. Ionizing radiation induces long-term senescence in endothelial cells through mitochondrial respiratory complex II dysfunction and superoxide generation. 2017 Free Radic. Biol. Med. pmid:28431961
Di Pietro M et al. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome. 2017 Mol. Hum. Reprod. pmid:28379469
Seo Y et al. Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy. 2017 Inflamm. Res. pmid:28364200
Schumacher F et al. The sphingosine 1-phosphate breakdown product, (2)-hexadecenal, forms protein adducts and glutathione conjugates in vitro. 2017 J. Lipid Res. pmid:28588048
Patmanathan SN et al. Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. 2017 Cell. Signal. pmid:28302566
Li S et al. Sphingosine-1-phosphate activates the AKT pathway to inhibit chemotherapy induced human granulosa cell apoptosis. 2017 Gynecol. Endocrinol. pmid:28277139
Garnero P The Utility of Biomarkers in Osteoporosis Management. 2017 Mol Diagn Ther pmid:28271451
Zeng Y Endothelial glycocalyx as a critical signalling platform integrating the extracellular haemodynamic forces and chemical signalling. 2017 J. Cell. Mol. Med. pmid:28211170
Sun XJ et al. Sphingosine-1-phosphate and its receptors in anti-neutrophil cytoplasmic antibody-associated vasculitis. 2017 Nephrol. Dial. Transplant. pmid:28206609
Al-Jarallah A and Oriowo M The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis. 2017 PLoS ONE pmid:28493876
Wang M et al. Automated tracking and quantification of angiogenic vessel formation in 3D microfluidic devices. 2017 PLoS ONE pmid:29136008
Tran HB et al. Disrupted epithelial/macrophage crosstalk via Spinster homologue 2-mediated S1P signaling may drive defective macrophage phagocytic function in COPD. 2017 PLoS ONE pmid:29112690
Ma S et al. A Brain-Region-Specific Neural Pathway Regulating Germinal Matrix Angiogenesis. 2017 Dev. Cell pmid:28535372
Meshcheryakova A et al. Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential. 2017 Expert Opin. Ther. Targets pmid:28524744
Ko J et al. Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy. 2017 Invest. Ophthalmol. Vis. Sci. pmid:28492873
Aoyama-Araki Y et al. Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma. 2017 Invest. Ophthalmol. Vis. Sci. pmid:28418499
Frej C et al. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex. 2017 Arterioscler. Thromb. Vasc. Biol. pmid:28385702
Nakajima M et al. The role of sphingosine-1-phosphate in the tumor microenvironment and its clinical implications. 2017 Tumour Biol. pmid:28381169
Garbowska M et al. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes. 2017 J. Cell. Physiol. pmid:28369933
Turner VM and Mabbott NA Ageing adversely affects the migration and function of marginal zone B cells. 2017 Immunology pmid:28369800
Müller J et al. Differential S1P Receptor Profiles on M1- and M2-Polarized Macrophages Affect Macrophage Cytokine Production and Migration. 2017 Biomed Res Int pmid:28367448
King A et al. Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis. 2017 Gastroenterology pmid:28363640
Wollny T et al. Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease. 2017 Int J Mol Sci pmid:28362332
Moruno-Manchon JF et al. Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease. 2017 Hum. Mol. Genet. pmid:28175299
Rojas-Canales D et al. Local Sphingosine Kinase 1 Activity Improves Islet Transplantation. 2017 Diabetes pmid:28174291
Dela Paz NG et al. Shear stress induces Gα activation independently of G protein-coupled receptor activation in endothelial cells. 2017 Am. J. Physiol., Cell Physiol. pmid:28148497
Green CL et al. The effects of graded levels of calorie restriction: IX. Global metabolomic screen reveals modulation of carnitines, sphingolipids and bile acids in the liver of C57BL/6 mice. 2017 Aging Cell pmid:28139067
Vishwakarma S et al. Altered Expression of Sphingosine-1-Phosphate Metabolizing Enzymes in Oral Cancer Correlate With Clinicopathological Attributes. 2017 Cancer Invest. pmid:28135860
Kurano M et al. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions. 2017 Arterioscler. Thromb. Vasc. Biol. pmid:28126827
Wang Y et al. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. 2017 Hepatology pmid:28120434
Silva VR et al. Hypothalamic S1P/S1PR1 axis controls energy homeostasis in Middle-Aged Rodents: the reversal effects of physical exercise. 2016 Aging (Albany NY) pmid:28039439
Lei YC et al. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure. 2016 World J. Gastroenterol. pmid:28028363
Al Fadel F et al. Involvement of Sphingosine 1-Phosphate in Palmitate-Induced Non-Alcoholic Fatty Liver Disease. 2016 Cell. Physiol. Biochem. pmid:28006772
Al Alam N and Kreydiyyeh SI FTY720P inhibits hepatic Na(+)-K(+) ATPase via S1PR2 and PGE2. 2016 Biochem. Cell Biol. pmid:27501354
Stolwijk JA et al. Calcium Signaling Is Dispensable for Receptor Regulation of Endothelial Barrier Function. 2016 J. Biol. Chem. pmid:27624938
Gharbaran R Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma. 2016 Tumour Biol. pmid:27317256
Higashi K et al. Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts. 2016 Bone pmid:27612439
Sasset L et al. Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis. 2016 Trends Endocrinol. Metab. pmid:27562337
Machida T et al. Cellular function and signaling pathways of vascular smooth muscle cells modulated by sphingosine 1-phosphate. 2016 J. Pharmacol. Sci. pmid:27581589
Nagahashi M et al. High levels of sphingolipids in human breast cancer. 2016 J. Surg. Res. pmid:27565080
Dong T et al. Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury. 2016 J Neuroinflammation pmid:27561600
Nojima H et al. Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes. 2016 PLoS ONE pmid:27551720
Harris CM et al. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats. 2016 J. Pharmacol. Exp. Ther. pmid:27519818
Gstalder C et al. FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model. 2016 Mol. Cancer Ther. pmid:27507852
Hashimoto Y et al. Sphingosine-1-phosphate-enhanced Wnt5a promotes osteogenic differentiation in C3H10T1/2 cells. 2016 Cell Biol. Int. pmid:27486054
Rumzhum NN et al. Effect of Sphingosine 1-Phosphate on Cyclo-Oxygenase-2 Expression, Prostaglandin E2 Secretion, and β2-Adrenergic Receptor Desensitization. 2016 Am. J. Respir. Cell Mol. Biol. pmid:26098693
Hollands A et al. Natural Product Anacardic Acid from Cashew Nut Shells Stimulates Neutrophil Extracellular Trap Production and Bactericidal Activity. 2016 J. Biol. Chem. pmid:27226531
Mirzaian M et al. Accurate quantification of sphingosine-1-phosphate in normal and Fabry disease plasma, cells and tissues by LC-MS/MS with (13)C-encoded natural S1P as internal standard. 2016 Clin. Chim. Acta pmid:27221202
Bao XH et al. [Role and related mechanism of S1P/S1P1 signal pathway during post conditioning of hypertrophic cardiomyocytes]. 2016 Zhonghua Xin Xue Guan Bing Za Zhi pmid:27220580
Marfia G et al. The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling. 2016 Stem Cells Dev. pmid:27217090
Versmissen J et al. Familial hypercholesterolaemia: cholesterol efflux and coronary disease. 2016 Eur. J. Clin. Invest. pmid:27208892
Sauvé M et al. Tumor Necrosis Factor/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in Diabetes. 2016 Diabetes pmid:27207546
Zhang XE et al. Activation of RhoA, but Not Rac1, Mediates Early Stages of S1P-Induced Endothelial Barrier Enhancement. 2016 PLoS ONE pmid:27187066
Ohtoyo M et al. Component of Caramel Food Coloring, THI, Causes Lymphopenia Indirectly via a Key Metabolic Intermediate. 2016 Cell Chem Biol pmid:27185637
Watterson SH et al. Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series. 2016 J. Med. Chem. pmid:26924461
Liu W et al. Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition. 2016 Eur. J. Pharmacol. pmid:26921757
Yang Y et al. Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions. 2016 Neurochem. Int. pmid:26921668
Park K et al. ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex. 2016 Proc. Natl. Acad. Sci. U.S.A. pmid:26903652
Bien-Möller S et al. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme. 2016 Oncotarget pmid:26887055
Uranbileg B et al. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence. 2016 PLoS ONE pmid:26886371
Chumanevich A et al. Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2. 2016 Mediators Inflamm. pmid:26884643
Deutsch G et al. Extensive macrophage accumulation in young and old Niemann-Pick C1 model mice involves the alternative, M2, activation pathway and inhibition of macrophage apoptosis. 2016 Gene pmid:26707209
Kim YH and Tabata Y Recruitment of mesenchymal stem cells and macrophages by dual release of stromal cell-derived factor-1 and a macrophage recruitment agent enhances wound closure. 2016 J Biomed Mater Res A pmid:26704185
Gomez-Muñoz A et al. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. 2016 Prog. Lipid Res. pmid:26703189
Ottenlinger F et al. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes. 2016 Eur. J. Immunol. pmid:26683421
Fan A et al. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells. 2016 Am. J. Physiol., Cell Physiol. pmid:26669941
Petrache I and Berdyshev EV Ceramide Signaling and Metabolism in Pathophysiological States of the Lung. 2016 Annu. Rev. Physiol. pmid:26667073
Delgado A and Martínez-Cartro M Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors. 2016 Curr. Med. Chem. pmid:26639095
Tan SF et al. Acid ceramidase is upregulated in AML and represents a novel therapeutic target. 2016 Oncotarget pmid:27825124
Li S et al. Sphk1 promotes breast epithelial cell proliferation via NF-κB-p65-mediated cyclin D1 expression. 2016 Oncotarget pmid:27811358
Scotti L et al. Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome. 2016 Mol. Hum. Reprod. pmid:27645281
Neubauer HA et al. An oncogenic role for sphingosine kinase 2. 2016 Oncotarget pmid:27588496
Nigro E et al. Role of adiponectin in sphingosine-1-phosphate induced airway hyperresponsiveness and inflammation. 2016 Pharmacol. Res. pmid:26462929
Melnik BC Rosacea: The Blessing of the Celts - An Approach to Pathogenesis Through Translational Research. 2016 Acta Derm. Venereol. pmid:26304030
Grammatikos G et al. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma. 2016 Oncotarget pmid:26933996